| Clearway Pain Solutions Institute | |
|
855 Downtowner Blvd, Mobile, AL 36609-5403 | |
| (850) 484-4080 | |
| (850) 484-8801 |
| Full Name | Clearway Pain Solutions Institute |
|---|---|
| Type | Facility |
| Speciality | Anesthesiology - Pain Medicine |
| Location | 855 Downtowner Blvd, Mobile, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134788359 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Clearway Pain Solutions Institute 201 Defense Hwy Ste 205, Annapolis, MD 21401-7096 Ph: (855) 527-7246 | Clearway Pain Solutions Institute 855 Downtowner Blvd, Mobile, AL 36609-5403 Ph: (850) 484-4080 |
News Archive
Stereotaxis, Inc. today reported its financial results for the quarter and the year ended December 31, 2009. Revenue for the recent fourth quarter grew 16% to $14.1 million compared with $12.1 million in the same quarter a year ago.
A drug developed by researchers at the Renaissance School of Medicine at Stony Brook University that targets enzymes involved in the development of pancreatic cancer cells is showing promise for improved treatment of metastatic pancreatic cancer.
The Amerigroup Foundation has awarded a grant of $15,000 to the Bronx Lebanon Hospital Center. Given in recognition of the center's commitment to helping create and maintain healthy, safe communities, the grant will support the Bronx Lebanon Hospital Center's continued efforts to improve the lives of the people it serves on a daily basis.
Raptor Pharmaceutical Corp., today announced the presentation of cystinosis data at the Annual Lysosomal Disease Network WORLD Symposium 2010, being held February 10-12 in Miami, Florida. Biomarker data from a Phase IIb pilot study of Raptor's proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") will be the subject of a poster titled, "Correlation of Plasma Cysteamine and WBC Cystine Levels at Steady State in Patients Treated with Cysteamine Bitartrate." The results will also be published in an upcoming issue of the journal Molecular Genetics and Metabolism.
At age 16, Chang Hun Lee was obese. In fact, at 185 pounds, he had already been diagnosed as prediabetic. Fortunately for Lee, he got his health back on track before it was too late. Now the senior at the University of Illinois' Gies College of Business wants to make sure others can be proactive about their health as well.
› Verified 4 days ago